# OncoHost to Present New Research on Early Detection of Immunotherapy Resistance Using Plasma Proteomics at ISLB 2026

- Source: PR Newswire M&A
- Published: 2026-11-05T07:54:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/oncohost-to-present-new-research-on-early-detection-of-immunotherapy-resistance-using-plasma-proteomics-at-islb-2026-302930430.html
- Canonical: https://groundlevelnews.com/story/oncohost-to-present-new-research-on-early-detection-of-immunotherapy-r-36d01f/

New data demonstrates the potential of longitudinal plasma proteomics to detect disease progression ahead of radiologic assessment and predict overall survival in advanced NSCLC BINYAMINA, Israel and CARY, N.C., Nov. 5, 2026 /PRNewswire/ -- OncoHost, a technology company transforming...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._